Article Details
Retrieved on: 2021-09-09 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... expected as the drug faces "near-term challenges," Biogen CEO Michel Vounatsos said at the Morgan Stanley health care conference Thursday.
Article found on: www.axios.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here